Biotec Company Presentation June 2012
-
Upload
sarahcoram -
Category
Documents
-
view
217 -
download
1
Transcript of Biotec Company Presentation June 2012
![Page 1: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/1.jpg)
![Page 2: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/2.jpg)
John [email protected] Development Manager
Paul [email protected] Development Manager
Sarah [email protected] Development Manager
Biotec Services International
![Page 3: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/3.jpg)
Who are Biotec?Your company of choice for temperature controlled pharmaceutical services. Through experience gained from over 15 years in the clinical supply arena, Biotec have assembled a team of dedicated professionals to ensure that every project we manage on your behalf is ‘In Safe Hands’ from initiation to completion.
Background•Founded in 1997•Privately owned•Split-site, purpose built GMP facilities licensed by the MHRA•Queen’s Award for Enterprise 2009
![Page 4: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/4.jpg)
Product ExperienceClassification Product typeBiologics Monoclonal antibodies
Therapeutic proteinsVaccinesViruses
Advanced Therapy Medicinal Products
Stem cellsGene therapies (GMO Biosafety level 2)Tissue engineered products
Small molecules OralInjectableTopicalInhalation
Controlled drugs Schedules 2 to 4Devices Patient use
Surgical use
![Page 5: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/5.jpg)
![Page 6: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/6.jpg)
![Page 7: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/7.jpg)
QP & GMP Consultancy• Seven QPs with wide experience of Biotec’s core service areas
• Advice to ensure speedy transition through regulatory hurdles utilizing Biotec’s unique ‘Product Supply Route Map’
• QP audits & familiarisation visits for IMP and Marketed Product importation providing a smooth path to release
• Expert knowledge regarding:• EU regulatory requirements• Label text compliance• Blinding issues
![Page 8: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/8.jpg)
![Page 9: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/9.jpg)
Clinical Supplies• Comprehensive clinical trials supply service by
combining:• In-house capabilities and expertise• Services of expert partners where appropriate
• Currently serve over 35 clients with one or more clinical projects – Phase I to III
• Global supply• Customer base spanning from West Coast USA to
Asia Pacific• Staff adept at handling multi-national, multi-cultural
trials
![Page 10: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/10.jpg)
Clinical Supplies• Management of unlicensed medicines through Biotec’s Specials supply
service• Manufacturers Specials Licence MS/19819• Continuation of supply to patients for compassionate use
• Biotec’s experienced Project Management team advantage• An average of 14 years industry experience• Extensive knowledge of handling challenging products and clinical trials• A flexible approach to reporting activities – tailored to client
requirements• Established team who strive to develop the relationship and stay with
the client throughout future projects
![Page 11: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/11.jpg)
![Page 12: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/12.jpg)
• Expert logistics team take control to reduce risk to client, patient and product• Handle shipping declarations and import/export documentation• Site specific advice available via ‘In Safe Hands’ video and proactive
communication
• Qualified shipping systems from ambient temperature to vapour phase nitrogen • Vast experience in handling ultra low temperature materials• Product specific qualification of shippers & transport systems if required
• Range of temperature monitoring options available to meet specific requirements
• Utilisation of partner depot network for global supply• 23 depots in key geographical locations
Global Logistics
![Page 13: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/13.jpg)
Global Logistics
![Page 14: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/14.jpg)
![Page 15: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/15.jpg)
GMP Temperature Controlled Storage• Proven track record of successful long term storage
for biologicals (up to Biosafety level 2), controlled drugs (Schedule 2 to 4), clinical and retain materials
• Flexible approach to storage offering single sample through to pallet size options at a range of temperatures
• Dual site storage managed via one point of contact
• ‘Rapid Response Service’ - reactive to expedited shipment requests to ensure that material is transferred rapidly
![Page 16: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/16.jpg)
![Page 17: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/17.jpg)
• Over 10 years experience handling ATMPs• Proven track record handling ultra low
temperature material• Technical support team to advise on specific
product handling options• Constant review of new technology to improve
Biotec’s service offering
Advanced Therapy Medicinal Products
![Page 18: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/18.jpg)
![Page 19: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/19.jpg)
• Managed through Biotec’s wholesaler Dealers licence
• Commercial supply activities segregated from clinical projects
• Strategy is to focus on niche products• Hospital supply• Orphan drugs• Difficult to handle, temperature sensitive products
• Expedited dispatch and global market delivery
Commercial Services
![Page 20: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/20.jpg)
….at Biotec StrategyCommunication Committed team who understand the clients needs
Low staff turnover – retention of client preferencesFlexible team to ensure all clients are offered a premium service
Project Management
Dedicated Project Manager assigned to each customerFirst point of call for queriesWork in partnership to achieve project goals
Expertise Experienced management, operational and Quality teamsLarge proportion of repeat business from a global client base Extensive experience with difficult to handle products
Forward Thinking Investment to meet client needsFocus on continuous improvement
The Biotec Approach
![Page 21: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/21.jpg)
![Page 22: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/22.jpg)
Biotec Facilities (Capacity)
Capacity Biotec House Biotec 2
Facility size 14,000 ft2 10,000 ft2
General warehousing 86 pallets 30 pallets
Controlled ambient 26 pallets 150 pallets
2-8°C 20 pallets 80 pallets plus 20,000 kits
-20°C 800 kits 50 pallets 2,000 kits
-80°C 340,000 vial locations
-
Liquid/vapour phase nitrogen 27 x 40 litre dewars -
![Page 23: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/23.jpg)
Regulatory History• Inspected by MHRA every two years since 2004 with the
adoption of the EU clinical trials directive 2001/20/EC• No critical or major observations during this time• Next inspection planned for May 2012
• Biotec possess the following licences• MIA 19819• MIA(IMP) 19819• Manufacturers Specials Licence MS/19819
• Also inspected annually by BMTRADA for verification of compliance to ISO9001:2008
• Regular client audits averaging two per month
![Page 24: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/24.jpg)
Clinical Supplies• Protocol interpretation for kit design and supply strategy
• IVR and IWR controlled studies
• Randomisation schedules and decode options
• Sourcing of comparators and ancillary products
• Label and leaflet design, translation and printing
• Primary packing
• Patient Pack assembly
• Global distribution
• Expiry date extension
• Returns, reconciliation and destruction
![Page 25: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/25.jpg)
• Shipment temperatures supported• +15ºC to +25ºC• +2ºC to +8ºC• -15ºC to -25ºC• -60ºC to -80ºC• -140ºC (dry shipper)
Global Logistics
![Page 26: Biotec Company Presentation June 2012](https://reader035.fdocuments.net/reader035/viewer/2022062412/58ef2f2b1a28aba0698b45b3/html5/thumbnails/26.jpg)
GMP Temperature Controlled Storage• Storage temperatures supported
• +15ºC to +25ºC• +2ºC to +8ºC• -15ºC to -25ºC• -80ºC• Vapour phase N2 (-140ºC)• Liquid N2 (-196ºC)